Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Director
-
Issuer Symbol
-
SION on Nasdaq
Peter A. Thompson - trading volume in the past year for Sionna Therapeutics, Inc.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
3,530,702 |
$157,398,695 |
$44.58 |
03 Feb 2026 |
Indirect |
|
|
| Non-Qualified Stock Option (right to buy) |
19,959 |
|
|
12 Jun 2025 |
Direct |
Common Stock |
|
| Series B convertible preferred stock |
0 |
|
|
10 Feb 2025 |
By OrbiMed Private Investments VIII, LP |
Common Stock |
|
| Series C convertible preferred stock |
0 |
|
|
10 Feb 2025 |
By OrbiMed Private Investments VIII, LP |
Common Stock |
|
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.